Delving into the Latest Updates on Diabetic retinopathy(OM Pharma) with Synapse

Overview

Basic Info

Drug Type

Chemical drugs

Synonyms-

Target-

Action-

Mechanism-

Therapeutic Areas

Cardiovascular DiseasesEndocrinology and Metabolic DiseaseEye Diseases

Active Indication

Diabetic Retinopathy

Inactive Indication-

Originator Organization

OM Pharma SA

Active Organization

OM Pharma SA

Inactive Organization-

Drug Highest PhasePreclinical

First Approval Date-

Regulation-

Recently, artificial intelligence algorithm has made great progress in the prediction of diabetic retinopathy based on fundus images，showing very high sensitivity and specificity. However，the real-world diagnosis effectiveness of deep learning model is still unclear.
This study is designed to evaluate the clinical efficacy of such an algorithm in detecting referable diabetic retinopathy.

Start Date01 Oct 2018

Sponsor / Collaborator

Shenzhen Second People's Hospital

NCT03572699

/ Unknown statusNot Applicable

Simple, Mobile-based Artificial Intelligence AlgoRithms in the Detection of Diabetic ReTinopathy (SMART) Study

This is an observational cross sectional study aimed to evaluate the performance of the artificial intelligence algorithm in detecting any grade of diabetic retinopathy using retinal images from patients with diabetes.

Start Date11 Jul 2018

Sponsor / Collaborator